SEC Form D · Amendment · filed January 12, 2017
Inozyme Pharma, Inc
Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
GUILFORD, CT
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗